View Older Stories View More Recent Stories

Apr 17, 2024 07:00AM STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting
Mar 14, 2024 04:39PM CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
Mar 14, 2024 04:39PM CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
Mar 6, 2024 07:00AM CytoSorbents to Report Fiscal 2023 Operating and Financial Results
Feb 8, 2024 07:00AM CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference
Jan 17, 2024 07:15AM Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients
Dec 28, 2023 07:00AM Cytosorbents (CTSO) Provides Update on the STAR-T Trial, Reports Final Independent Data and Safety Monitoring Board Recommendation
Dec 28, 2023 07:00AM CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation
Dec 13, 2023 09:15AM CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering
Nov 9, 2023 04:15PM CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
Oct 27, 2023 07:00AM CytoSorbents to Report Third Quarter 2023 Operating and Financial Results
Oct 5, 2023 07:00AM CytoSorbents to Present at the 8th Annual Dawson James Conference
Sep 27, 2023 07:00AM CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry
Sep 19, 2023 07:03AM Cytosorbents (CTSO) Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer
Sep 19, 2023 07:00AM CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer
Sep 11, 2023 11:32AM CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation
Sep 1, 2023 04:46PM Cytosorbents (CTSO) Announces CFO Resignation
Sep 1, 2023 04:43PM CytoSorbents Announces Resignation of Chief Financial Officer Alexander D’Amico
Aug 31, 2023 07:00AM CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
Aug 14, 2023 07:00AM CytoSorbents Completes U.S. and Canadian STAR-T Pivotal Trial
Aug 1, 2023 04:15PM CytoSorbents Reports Second Quarter 2023 Financial and Operational Results
Jul 26, 2023 07:00AM CytoSorbents to Report Second Quarter 2023 Operating and Financial Results
Jul 19, 2023 07:02AM Cytosorbents (CTSO) Appoints Alexander D’Amico as CFO
Jul 19, 2023 07:00AM CytoSorbents Appoints Alexander D’Amico as Chief Financial Officer
Jul 11, 2023 07:02AM Cytosorbents (CTSO) And Humedics Announce Theranostic Collaboration in the Field of Liver Disease
Jul 11, 2023 07:00AM CytoSorbents And Humedics Announce Theranostic Collaboration in the Field of Liver Disease
Jul 7, 2023 07:07AM CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial
Jun 15, 2023 07:01AM Cytosorbents (CTSO) Announces Independent Data Safety and Monitoring Board Recommends Completion of the Pivotal STAR-T Trial
Jun 15, 2023 07:00AM CytoSorbents Announces Independent Data Safety and Monitoring Board Recommends Completion of the Pivotal STAR-T Trial Without Modifications Following Second Scheduled Safety Review
Jun 5, 2023 09:00AM CytoSorbents This Week to Host its Virtual Annual Stockholders Meeting and to Present at the Jefferies Healthcare Conference
Jun 5, 2023 09:00AM CytoSorbents This Week to Host its Virtual Annual Stockholders Meeting and to Present at the Jefferies Healthcare Conference
May 2, 2023 04:15PM CytoSorbents Reports First Quarter 2023 Results
May 2, 2023 04:15PM CytoSorbents Reports First Quarter 2023 Results
Apr 26, 2023 07:00AM CytoSorbents to Report First Quarter 2023 Operating and Financial Results
Apr 26, 2023 07:00AM CytoSorbents to Report First Quarter 2023 Operating and Financial Results
Apr 20, 2023 07:03AM Cytosorbents (CTSO) Pivotal STAR-T Trial Reaches Second Key Milestone
Apr 20, 2023 07:00AM CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled
Apr 20, 2023 07:00AM CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled
Apr 19, 2023 07:00AM Cytosorbents (CTSO) Announces Retirement of Board Chair
Apr 19, 2023 07:00AM CytoSorbents Announces Board Chairman Al W. Kraus To Retire
Apr 19, 2023 07:00AM CytoSorbents Announces Board Chairman Al W. Kraus To Retire
Mar 29, 2023 08:32AM Cytosorbents (CTSO) Reports Publication Underscoring Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic Hyperinflammation
Mar 29, 2023 08:30AM Landmark Publication Underscores Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic Hyperinflammation
Mar 29, 2023 08:30AM Landmark Publication Underscores Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic Hyperinflammation
Mar 22, 2023 08:14AM Cytosorbents (CTSO) Highlights New Clinical Data from Current Studies
Mar 22, 2023 08:09AM CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)
Mar 22, 2023 08:09AM CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)
Mar 14, 2023 07:00AM CytoSorbents Comments on Bank Exposure and Diversified Cash Position
Mar 14, 2023 07:00AM CytoSorbents Comments on Bank Exposure and Diversified Cash Position
Mar 9, 2023 04:15PM CytoSorbents Reports Fourth Quarter and Full Year 2022 Results
View More Recent Stories View Older Stories